| Medical and Health Sciences | 2021-2025 | 55 | US 26 | 99.99 |
| Public, Environmental and Occupational Health | Lifetime | 564 | US 284 | 99.21 |
| Hematology | Lifetime | 198 | US 104 | 98.89 |
| Medical Genetics | Lifetime | 375 | US 194 | 96.83 |
| Public, Environmental and Occupational Health | 2021-2025 | 5 | US 4 | 99.96 |
| Hematology | 2021-2025 | 4 | US 3 | 99.95 |
| Medical Genetics | 2021-2025 | 28 | US 16 | 99.36 |
| Molecular Biology | 2021-2025 | 938 | US 263 | 94.70 |
| Oncology | 2021-2025 | 419 | US 183 | 94.96 |
| Acute Myeloid Leukemia Research | Lifetime | 269 | US 136 | 99.22 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 171 | US 84 | 99.07 |
| Acute Lymphoblastic Leukemia research | Lifetime | 218 | US 122 | 99.10 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 150 | US 78 | 98.71 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 515 | US 239 | 98.63 |
| Histone Deacetylase Inhibitors Research | Lifetime | 195 | US 120 | 97.97 |
| Multiple Myeloma Research and Treatments | Lifetime | 420 | US 193 | 97.72 |
| CAR-T cell therapy research | Lifetime | 963 | US 550 | 97.56 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 871 | US 416 | 96.87 |
| Protein Degradation and Inhibitors | Lifetime | 654 | US 321 | 95.60 |
| Eosinophilic Disorders and Syndromes | Lifetime | 753 | US 306 | 95.00 |
| Neutropenia and Cancer Infections | Lifetime | 735 | US 313 | 94.43 |
| Science, Research, and Medicine | Lifetime | 729 | US 354 | 69.05 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 3 | US 3 | 99.96 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 3 | US 3 | 99.95 |
| Acute Myeloid Leukemia Research | 2021-2025 | 8 | US 8 | 99.95 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 8 | US 5 | 99.80 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 12 | US 10 | 99.63 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 9 | US 8 | 99.57 |
| Neutropenia and Cancer Infections | 2021-2025 | 11 | US 5 | 98.64 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 28 | US 15 | 99.17 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 94 | US 46 | 98.94 |
| CAR-T cell therapy research | 2021-2025 | 194 | US 107 | 98.61 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 83 | US 40 | 98.87 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 42 | US 30 | 98.10 |
| Protein Degradation and Inhibitors | 2021-2025 | 118 | US 59 | 97.41 |
| Hematological disorders and diagnostics | 2021-2025 | 72 | US 28 | 86.92 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 85 | US 38 | 87.33 |
| Bone and Joint Diseases | 2021-2025 | 637 | US 102 | 76.76 |
| Polyomavirus and related diseases | 2021-2025 | 676 | US 229 | 76.10 |
